{"id":16858,"date":"2022-09-23T12:22:26","date_gmt":"2022-09-23T12:22:26","guid":{"rendered":"https:\/\/www.aktionlegal.com\/?p=16858"},"modified":"2024-10-08T17:04:32","modified_gmt":"2024-10-08T17:04:32","slug":"aktion-ha-asesorado-a-medical-plasmas-en-el-cierre-de-una-ronda-de-financiacion-de-15me","status":"publish","type":"post","link":"https:\/\/www.aktionlegal.com\/en\/aktion-ha-asesorado-a-medical-plasmas-en-el-cierre-de-una-ronda-de-financiacion-de-15me\/","title":{"rendered":"Aktion asesora a MEDICAL PLASMAS en el cierre de una ronda de financiaci\u00f3n de 1,5M\u20ac\u00a0"},"content":{"rendered":"<p>Medical Plasmas is a company born from the research activity of Daniel Cort\u00e1zar and Ana Meg\u00eda Mac\u00edas, dedicated to the development, manufacture and commercialization of cold atmospheric plasma technologies and solutions for applications in human medicine, as well as the provision of associated services.&nbsp;&nbsp;<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-color wp-block-heading\" style=\"color:#85afc6\"> <strong>Who has been involved in this operation?<\/strong>\u00a0<\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><a href=\"https:\/\/clave.capital\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow sponsored\">Clave Capital<\/a>, a venture capital manager with 20 years of experience, through its financial vehicles I+D+I Tech Transfer F.C.R and Navarra Tech Transfer F.C.R, has led the financing round. They have been joined by the Center for the Development of Industrial Technology (CDTI).&nbsp;&nbsp;<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-color wp-block-heading\" style=\"color:#85afc6\"><strong>What do they achieve with this operation?<\/strong>\u00a0<\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>With this operation, <a href=\"https:\/\/medicalplasmas.com\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow sponsored\">Medical Plasmas<\/a> consolidates the bases to be able to develop a device with a first focus on the treatment of ulcers or wounds, in addition to carrying out a clinical trial and obtaining the CE certificate for its commercialization.&nbsp;&nbsp;<\/p>\n\n\n\n<p>In this sense, its founders also foresee being able to extend the application of cold atmospheric plasma to other pathologies. Both have worked in close collaboration with Bernardo Hontanilla, a physician specializing in Plastic, Aesthetic and Reconstructive Surgery, and director of the clinical trials to be carried out at the Cl\u00ednica Universidad de Navarra and the Hospital Universitario de Navarra.&nbsp;<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Congratulations, team! From AKTION we are very proud to have accompanied and advised you in this operation.&nbsp;<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\"><\/h3>","protected":false},"excerpt":{"rendered":"<p>Medical Plasmas es una compa\u00f1\u00eda nacida de la actividad investigadora de Daniel Cort\u00e1zar y Ana Meg\u00eda Mac\u00edas, dedicada al desarrollo, fabricaci\u00f3n y comercializaci\u00f3n de tecnolog\u00edas y soluciones de plasma atmosf\u00e9rico fr\u00edo para aplicaciones en medicina humana, as\u00ed como la prestaci\u00f3n de servicios asociados.&nbsp;&nbsp; \u00bfQui\u00e9n ha participado en esta operaci\u00f3n?\u00a0 Clave Capital, gestora de capital riesgo [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":16860,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[98],"class_list":["post-16858","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-casos-de-exito","tag-venture-capital-transactions"],"_links":{"self":[{"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/posts\/16858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/comments?post=16858"}],"version-history":[{"count":0,"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/posts\/16858\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/media\/16860"}],"wp:attachment":[{"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/media?parent=16858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/categories?post=16858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aktionlegal.com\/en\/wp-json\/wp\/v2\/tags?post=16858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}